Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 MALADIE RÉSEAU REGISTRY PROJECTS SE CONNECTER
 
 
  
Imaging -
--->Nouvelles
[-]Projet
--->Sponsor
--->[-]Conseil d'administration (EC)
--->Arnesen
--->Blumenstein
--->Burgunder
--->Craufurd
--->Humbert
--->Jones
--->Kremer
--->Reilmann
--->Roos
--->Rosser
--->Weydt
--->Capper-Loup
--->Feihle
--->Levey
--->McLean
--->Documents publics
--->[-]Writing Committee Strategic ...
--->Dates
--->[-]Conseil scientifique et bio-éth...
--->Becanovic
--->Busse
--->Frontali
--->Giorgini
--->Holmans
--->Mariotti
--->Norremolle
--->Reetz
--->Rickards
--->Saft
--->van Duijn
--->Valenza
--->Verellen
--->Public Documents
--->Coordination centrale
--->Coordination linguistique
--->Fellowship Programme
--->[-]Constitution
--->Article 1
--->Article 2
--->Article 3
--->Article 4
--->Article 5
--->Article 6
--->Article 7
--->Article 8
--->Article 9
--->Article 10
--->Article 11
--->Article 12
--->Documents
--->[-]Elections
--->[-]Adhésion
--->Demande
[-]Pays
--->[+]Autriche
--->[+]Belgique
--->[+]République Tchèque
--->[+]Danemark
--->[+]Finlande
--->[+]France
--->[+]Allemagne
--->[+]Ireland
--->[+]Italie
--->[+]Pays-Bas
--->[+]Norvège
--->[+]Pologne
--->[+]Portugal
--->[+]Russia
--->[+]Espagne
--->[+]Suède
--->[+]Suisse
--->[+]Royaume-Uni
--->[+]Outside Europe
[-]Groupes de travail
--->[-]Advanced HD
--->Dates
--->[+]Meetings
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[-]Biomarkers
--->[+]Dates
--->[+]Meetings
--->[+]Brain and Tissue Banking
--->[-]Cognitive Phenotype
--->[+]Dates
--->[+]Meetings
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[-]Genetic Modifiers
--->[+]Dates
--->[+]Meetings
--->[+]Health Economics
--->[-]Imaging
--->[+]Dates
--->[+]Meetings
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[-]Physiotherapy
--->Dates
--->[+]Meetings
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[-]Symptomatic Research
--->[+]Dates
--->[+]Meetings
--->[+]Young Adults
[-]Evénements
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Communication
--->Contact EHDN
--->Chat Rooms
--->Liste email - public
--->Newsletter
--->Offres d'emploi
datedescriptiontailleauteur document 
04.08.26Alterations in iron content in the brain of Huntington Disease mutation carriers in comparison with healthy control subjects32 kBanonymousapplication/mswordg05-alterations-in-iron-content 
04.08.26Iron defect is implicated in white matter changes in Huntington Disease32 kBanonymousapplication/mswordg06-iron-defect 
04.08.26Reliability of diffusion tensor imaging measures32 kBanonymousapplication/mswordg07-diffusion-tensor-imaging-measures 
04.08.26Brain Structure in Children at Risk for Huntington’s Disease32 kBanonymousapplication/mswordg04-brain-structure-in-children-at-risk 
04.08.26Corpus callosal atrophy in Huntington’s Disease32 kBanonymousapplication/mswordg03-corpus-callosal-atrophy 
04.08.26Evaluation of multi-modal, multi-site imaging measures in Huntington’s Disease: baseline results from the Paddington study32 kBanonymousapplication/mswordg01-imaging-measures-paddington 
04.08.26Brain structure in preclinical Huntington’s disease: a multimethod approach32 kBanonymousapplication/mswordg02-brain-structure-in-preclinical-hd 
04.08.26A multicentre approach for the detection of patterns of impairment in Huntington’s Disease by using diffusion tensor imaging32 kBanonymousapplication/mswordg08-detection-of-patterns-of-impairmen... 
04.08.26Structural connectivity-based topography of the basal ganglia is altered in premanifest and early manifest Huntington’s Disease32 kBanonymousapplication/mswordg09-topography-basal-ganglia 
04.08.26Brain activation and functional connectivity in premanifest Huntington’s disease during states of intrinsic and phasic alertness32 kBanonymousapplication/mswordg14-brain-activation-functional-connec... 
04.08.26Switch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington disease – a PET study32 kBanonymousapplication/mswordg15-switch-of-cerebral-a1-adenosine-re... 
04.08.26Abnormal responses to visual cortex activation in early stage Huntington Disease patients using 31P-NMR spectroscopy32 kBanonymousapplication/mswordg13-visual-cortex-activation-in-early-... 
04.08.26From premanifest to manifest Huntington’s disease: a two year follow up study with magnetic resonance spectroscopy at 7 Tesla32 kBanonymousapplication/mswordg12-from-premanifest-to-manifest 
04.08.26Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of huntington disease patients32 kBanonymousapplication/mswordg10-correlation-relaxometry-and-diffus... 
04.08.26Tractography of the corpus callosum in Huntington Disease32 kBanonymousapplication/mswordg11-tractography-of-corpus-callosum 
04.08.26Does CAG repeat length modulate rates of brain atrophy in Huntington’s Disease?32 kBanonymousapplication/mswordg0x-cag-repeat-length-brain-atrophy 

Le dossier contient 16 documents.
about us | privacy statement | disclaimer | terms of use